PRESS RELEASES
<< Back
Xcel Brands, Inc. Announces Fourth Quarter And Fiscal Year 2022 Results
- Company provides update on strategic transformation to pursue live streaming and social commerce across all digital channels.
- Transition creates an asset light business model and is expected to produce over
$10 million in operating cost savings on an annualized basis starting in Q2 2023.
Strategic Transformation
In the first quarter of 2023, Xcel began to restructure its business operations by entering into new licensing agreements and joint venture arrangements with best-in-class business partners. The Company entered into a new interactive television licensing agreement with America’s
Within its apparel business, similar transactions have recently been executed. In conjunction with the launch of the C Wonder Brand on HSN, Xcel licensed the wholesale production operations related to the brand to
For its
Fourth Quarter 2022 Financial Results
Total revenue was
Net loss attributable to
Full Year 2022 Financial Results
Total revenue was
Net loss attributable to
Balance Sheet
The Company's balance sheet at
About
Forward Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical fact contained in this press release, including statements regarding future events, our future financial performance, business strategy and plans and objectives of management for future operations, are forward-looking statements. We have attempted to identify forward-looking statements by terminology including "anticipates," "believes," "can," "continue," "ongoing," "could," "estimates," "expects," "intends," "may," "appears," "suggests," "future," "likely," "goal," "plans," "potential," "projects," "predicts," "seeks," "should," "would," "guidance," "confident" or "will" or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements regarding our anticipated revenue, expenses, profitability, strategic plans, and capital needs. These statements are based on information available to us on the date hereof and our current expectations, estimates and projections and are not guarantees of future performance. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and other factors, including, without limitation, the risks discussed in the "Risk Factors" section and elsewhere in the Company's Annual Report on form 10-K for the year ended
For further information please contact:
216-464-6400
andrew@smberger.com
Unaudited Consolidated Statements of Operations | ||||||||||||||||
(in thousands, except share and per share data) | ||||||||||||||||
For the Three Months Ended | For the Twelve Months Ended | |||||||||||||||
2022 | 2021 | 2022 | 2021 | |||||||||||||
Revenues | ||||||||||||||||
Net licensing revenue | $ | 1,435 | $ | 4,491 | $ | 14,737 | $ | 21,876 | ||||||||
Net sales | 2,631 | 3,607 | 11,044 | 16,056 | ||||||||||||
Net revenue | 4,066 | 8,098 | 25,781 | 37,932 | ||||||||||||
Cost of goods sold (sales) | 2,265 | 2,904 | 7,980 | 10,667 | ||||||||||||
Gross profit | 1,801 | 5,194 | 17,801 | 27,265 | ||||||||||||
Operating costs and expenses | ||||||||||||||||
Salaries, benefits and employment taxes | 3,412 | 4,249 | 16,802 | 16,535 | ||||||||||||
Other selling, general and administrative expenses | 4,624 | 4,773 | 15,386 | 14,364 | ||||||||||||
Stock-based compensation | 52 | (34 | ) | 620 | 720 | |||||||||||
Depreciation and amortization | 1,816 | 1,881 | 7,263 | 6,830 | ||||||||||||
Asset impairment charges | 274 | 1,372 | 274 | 1,372 | ||||||||||||
Total operating costs and expenses | 10,178 | 12,241 | 40,345 | 39,821 | ||||||||||||
Other Income | ||||||||||||||||
Gain on Reduction of Contingent Obligation | 900 | - | 900 | - | ||||||||||||
Income/(Loss) on Equity invest | (925 | ) | - | (1,202 | ) | - | ||||||||||
Gain on sale of assets | (22.00 | ) | - | 20,586 | - | |||||||||||
Total other income | (47 | ) | 20,284 | - | ||||||||||||
Operating loss | (8,424 | ) | (7,047 | ) | (2,260 | ) | (12,556 | ) | ||||||||
Interest and finance expense | ||||||||||||||||
Interest expense - term loan debt | - | 553 | 1,187 | 1,916 | ||||||||||||
Other interest and finance charges (income), net | 22 | 20 | 16 | 147 | ||||||||||||
Loss on extinguishment of debt | - | 695 | 2,324 | 1,516 | ||||||||||||
Total interest and finance expense | 22 | 1,268 | 3,527 | 3,579 | ||||||||||||
Loss before income taxes | (8,446 | ) | (8,315 | ) | (5,787 | ) | (16,135 | ) | ||||||||
Income tax benefit | (2,070 | ) | (1,087 | ) | (431 | ) | (3,106 | ) | ||||||||
Net loss | (6,376 | ) | (7,228 | ) | (5,356 | ) | (13,029 | ) | ||||||||
Less: Net loss attributable to noncontrolling interest | (397 | ) | (285 | ) | (1,338 | ) | (845 | ) | ||||||||
Net loss attributable to |
$ | (5,979 | ) | $ | (6,943 | ) | $ | (4,018 | ) | $ | (12,184 | ) | ||||
Loss per common share attributed to |
||||||||||||||||
Basic net loss per share | $ | (0.30 | ) | $ | (0.35 | ) | $ | (0.20 | ) | $ | (0.63 | ) | ||||
Weighted average number of common shares outstanding: | ||||||||||||||||
Basic and diluted weighted average common shares outstanding | 19,624,860 | 19,567,318 | 19,624,669 | 19,455,987 | ||||||||||||
Unaudited Consolidated Balance Sheets | |||||||||
(in thousands, except share and per share data) | |||||||||
Assets | |||||||||
Current Assets: | |||||||||
Cash and cash equivalents | $ | 4,608 | $ | 4,483 | |||||
Accounts receivable, net | 5,110 | 7,640 | |||||||
Inventory | 2,845 | 3,375 | |||||||
Prepaid expenses and other current assets | 1,457 | 1,681 | |||||||
Total current assets | 14,020 | 17,179 | |||||||
Property and equipment, net | 1,418 | 2,549 | |||||||
Operating lease right-of-use assets | 5,420 | 6,314 | |||||||
Trademarks and other intangibles, net | 47,665 | 98,304 | |||||||
Equity method investment | 19,195 | - | |||||||
Restricted cash | - | 739 | |||||||
Deferred tax assets, net | 1,107 | 141 | |||||||
Other assets | 110 | 555 | |||||||
Total non-current assets | 74,915 | 108,602 | |||||||
Total Assets | $ | 88,935 | $ | 125,781 | |||||
Liabilities and Stockholders' Equity | |||||||||
Current Liabilities: | |||||||||
Accounts payable, accrued expenses and other current liabilities | $ | 3,958 | $ | 6,233 | |||||
Accrued income taxes payable | 568 | ||||||||
Accrued payroll | 416 | 577 | |||||||
Accrued consideration payable | - | - | |||||||
Current portion of operating lease obligation | 1,376 | 1,207 | |||||||
Current portion of long-term debt | - | 2,500 | |||||||
Current portion of contingent obligations | 243 | ||||||||
Total current liabilities | 6,561 | 10,517 | |||||||
Long-Term Liabilities: | |||||||||
Long-term portion of operating lease obligation | 5,839 | 7,252 | |||||||
Long-term debt, net, less current portion | - | 25,531 | |||||||
Contingent obligations | 6,396 | 7,539 | |||||||
Total long-term liabilities | 12,235 | 40,322 | |||||||
Total Liabilities | 18,796 | 50,839 | |||||||
Commitments and Contingencies | |||||||||
Stockholders' Equity: | |||||||||
Preferred stock, |
- | - | |||||||
Common stock, |
20 | 20 | |||||||
Paid-in capital | 103,592 | 103,039 | |||||||
Accumulated deficit | (32,797 | ) | (28,779 | ) | |||||
Total Xcel Brands, Inc. stockholders' equity | 70,815 | 74,280 | |||||||
Noncontrolling interest | (676 | ) | 662 | ||||||
Total Stockholders' Equity | 70,139 | 74,942 | |||||||
Total Liabilities and Stockholders' Equity | $ | 88,935 | $ | 125,781 | |||||
Unaudited Consolidated Statements of Cash Flows | |||||||||
(in thousands) | |||||||||
For the Twelve Months Ended | |||||||||
2022 | 2021 | ||||||||
Cash flows from operating activities | |||||||||
Net loss | $ | (5,356 | ) | $ | (13,029 | ) | |||
Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||||
Depreciation and amortization expense | 7,263 | 6,830 | |||||||
Asset impairment charges | 274 | 1,372 | |||||||
Amortization of deferred finance costs | 156 | 308 | |||||||
Stock-based compensation | 620 | 720 | |||||||
Allowance for doubtful accounts | 413 | 102 | |||||||
Undistributed proportional share of net income of equity method investee | 1,202 | - | |||||||
Loss on early extinguishment of debt | 2,324 | 1,516 | |||||||
Deferred income tax benefit | (965 | ) | (3,192 | ) | |||||
Gain on sale of majority interest in Isaac Mizrahi brand | (20,586 | ) | - | ||||||
Gain on reduction of contingent obligation | (900 | ) | - | ||||||
Changes in operating assets and liabilities: | |||||||||
Accounts receivable | 2,117 | 1,147 | |||||||
Inventory | 530 | (2,159 | ) | ||||||
Prepaid expenses and other assets | 566 | (818 | ) | ||||||
Accounts payable, accrued expenses and other current liabilities | (1,596 | ) | 1,228 | ||||||
Lease-related assets and liabilities | (244 | ) | (581 | ) | |||||
Net cash used in operating activities | (14,182 | ) | (6,556 | ) | |||||
Cash flows from investing activities | |||||||||
Net proceeds from sale of majority interest in Isaac Mizrahi brand | 45,386 | - | |||||||
Capital contribution to equity method investee | (600 | ) | - | ||||||
Cash consideration for acquisition of Lori Goldstein assets | - | (3,661 | ) | ||||||
Purchase of other intangible assets | - | (39 | ) | ||||||
Purchase of property and equipment | (265 | ) | (1,095 | ) | |||||
Net cash provided by (used in) investing activities | 44,521 | (4,795 | ) | ||||||
Cash flows from financing activities | |||||||||
Proceeds from exercise of stock options | - | 5 | |||||||
Shares repurchased including vested restricted stock in exchange for withholding taxes | (442 | ) | (16 | ) | |||||
Cash contribution from non-controlling interest | - | 1,000 | |||||||
Proceeds from revolving loan debt | - | - | |||||||
Proceeds from long-term debt | - | 54,000 | |||||||
Payment of deferred finance costs | - | (2,173 | ) | ||||||
Payment of long-term debt | (29,000 | ) | (41,750 | ) | |||||
Payment of breakage fees associated with extinguishment of long-term debt | (1,511 | ) | (559 | ) | |||||
Net cash (used in) provided by financing activities | (30,953 | ) | 10,507 | ||||||
Net decrease in cash, cash equivalents, and restricted cash | (614 | ) | (844 | ) | |||||
Cash, cash equivalents, and restricted cash at beginning of period | 5,222 | 6,066 | |||||||
Cash, cash equivalents, and restricted cash at end of period | $ | 4,608 | $ | 5,222 | |||||
Reconciliation to amounts on consolidated balance sheets: | |||||||||
Cash and cash equivalents | 4,608 | $ | 4,483 | ||||||
Restricted cash | - | 739 | |||||||
Total cash, cash equivalents, and restricted cash | $ | 4,608 | $ | 5,222 | |||||
Supplemental disclosure of non-cash activities: | |||||||||
Contingent obligation related to acquisition of Lori Goldstein assets at fair value | $ | - | $ | 6,639 | |||||
Liability for equity-based bonuses | $ | (283 | ) | $ | (13 | ) | |||
Supplemental disclosure of cash flow information: | |||||||||
Cash paid during the year for income taxes | $ | 1,032 | $ | 1,799 | |||||
Cash paid during the year for interest | $ | - | $ | 91 | |||||
Non-GAAP net income and non-GAAP diluted EPS are non-GAAP unaudited terms. We define non-GAAP net income as net income (loss) attributable to
Adjusted EBITDA is a non-GAAP unaudited measure, which we define as net income (loss) attributable to
Management uses non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA as measures of operating performance to assist in comparing performance from period to period on a consistent basis and to identify business trends relating to our results of operations. Management believes non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are also useful because these measures adjust for certain costs and other events that management believes are not representative of our core business operating results, and thus these non-GAAP measures provide supplemental information to assist investors in evaluating our financial results.
Non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA should not be considered in isolation or as alternatives to net income, earnings per share, or any other measure of financial performance calculated and presented in accordance with GAAP. Given that non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA are financial measures not deemed to be in accordance with GAAP and are susceptible to varying calculations, our non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA may not be comparable to similarly titled measures of other companies, including companies in our industry, because other companies may calculate these measures in a different manner than we do. In evaluating non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA, you should be aware that in the future we may or may not incur expenses similar to some of the adjustments in this document. Our presentation of non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA does not imply that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider non-GAAP net income, non-GAAP diluted EPS, and Adjusted EBITDA alongside other financial performance measures, including our net income and other GAAP results, and not rely on any single financial measure.
Three Months Ended | For the Twelve Months Ended | ||||||||||||||
($ in thousands) | |||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Net loss attributable to |
$ | (5,979 | ) | (6,943 | ) | $ | (4,018 | ) | (12,184 | ) | |||||
Amortization of trademarks | 1,520 | 1,520 | 6,079 | 5,435 | |||||||||||
Proportional share of amortization of equity method investee | 460 | - | 1,202 | ||||||||||||
Stock-based compensation | 52 | (34 | ) | 620 | 720 | ||||||||||
Loss on early extinguishment of debt | - | 695 | 2,324 | 1,516 | |||||||||||
Gain on reduction of contingent obligations | (900 | ) | - | (900 | ) | - | |||||||||
Certain adjustments to allowance for doubtful accounts | 413 | - | 413 | 132 | |||||||||||
Asset impairment | 274 | 1,372 | 274 | 1,372 | |||||||||||
Gain on the sale of assets | 22 | - | (20,586 | ) | |||||||||||
Deferred income tax benefit | (2,070 | ) | (1,173 | ) | (431 | ) | (3,192 | ) | |||||||
Non-GAAP net (loss) | $ | (6,208 | ) | $ | (4,563 | ) | $ | (15,023 | ) | $ | (6,201 | ) | |||
Three Months Ended | For the Twelve Months Ended | ||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Diluted loss per share attributable to |
$ | (0.30 | ) | $ | (0.35 | ) | $ | (0.20 | ) | $ | (0.63 | ) | |||
Amortization of trademarks | 0.08 | 0.08 | 0.31 | 0.28 | |||||||||||
Proportional share of amortization of equity method investee | 0.02 | - | 0.06 | ||||||||||||
Stock-based compensation | - | - | 0.03 | 0.04 | |||||||||||
Loss on early extinguishment of debt | - | 0.04 | 0.12 | 0.08 | |||||||||||
Gain on reduction of contingent obligations | (0.04 | ) | - | (0.05 | ) | - | |||||||||
Certain adjustments to allowance for doubtful accounts | 0.02 | - | 0.02 | 0.01 | |||||||||||
Asset impairment | 0.01 | 0.07 | 0.01 | 0.07 | |||||||||||
Gain on the sale of assets | - | - | (1.05 | ) | - | ||||||||||
Deferred income tax benefit | (0.11 | ) | (0.06 | ) | (0.02 | ) | (0.17 | ) | |||||||
Non-GAAP diluted EPS | $ | (0.32 | ) | $ | (0.22 | ) | $ | (0.77 | ) | $ | (0.32 | ) | |||
Non-GAAP weighted average diluted shares | 19,624,860 | 19,567,318 | 19,624,669 | 19,455,987 | |||||||||||
Three Months Ended | For the Twelve Months Ended | ||||||||||||||
($ in thousands) | |||||||||||||||
2022 | 2021 | 2022 | 2021 | ||||||||||||
(Unaudited) | (Unaudited) | (Unaudited) | (Unaudited) | ||||||||||||
Net loss attributable to |
$ | (5,979 | ) | $ | (6,943 | ) | $ | (4,018 | ) | $ | (12,184 | ) | |||
Depreciation and amortization | 1,816 | 1,881 | 7,263 | 6,830 | |||||||||||
Proportional share of amortization of equity method investee | 460 | - | 1,202 | - | |||||||||||
Interest and finance expense | 22 | 1,268 | 3,527 | 3,579 | |||||||||||
Income tax benefit | (2,070 | ) | (1,087 | ) | (431 | ) | (3,106 | ) | |||||||
State and local franchise taxes | (19 | ) | 37 | 102 | 142 | ||||||||||
Stock-based compensation | 52 | (34 | ) | 620 | 720 | ||||||||||
Gain on reduction of contingent obligations | (900 | ) | - | (900 | ) | - | |||||||||
Certain adjustments to allowance for doubtful accounts | 413 | - | 413 | 132 | |||||||||||
Gain on the sale of assets | 22 | - | (20,586 | ) | - | ||||||||||
Asset impairment | 274 | 1,372 | 274 | 1,372 | |||||||||||
Adjusted EBITDA | $ | (5,909 | ) | $ | (3,506 | ) | $ | (12,534 | ) | $ | (2,515 | ) | |||
Source: Xcel Brands, Inc